|
Re: Question for BDAZ or BKC
|
2
|
Resverlogix Corp.
|
Jun 02, 2018 01:01PM
|
|
Re: Esperion
|
2
|
Resverlogix Corp.
|
Mar 20, 2017 12:01PM
|
|
Re: Bear
|
2
|
Resverlogix Corp.
|
Jul 19, 2020 03:06PM
|
|
Re: When to expect the 250th Event
|
2
|
Resverlogix Corp.
|
Feb 26, 2019 07:30PM
|
|
Re: Can we expect for 5 point MACE to be near our phase 2 trials results
|
2
|
Resverlogix Corp.
|
Apr 02, 2019 01:08PM
|
|
Re: Managed to catch up with Mark Day last night...
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 01:04PM
|
|
Re: 3rd Quarter Financial Statements
|
2
|
Resverlogix Corp.
|
Mar 15, 2017 10:27PM
|
|
Re: Answer from IR - 250 confrimed MACE would require disclosure
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 10:48AM
|
|
Zenith has been quiet.......too quiest
|
2
|
Zenith Epigenetics
|
Jun 03, 2016 02:25PM
|
|
Re: Debt and 28 August
|
2
|
Resverlogix Corp.
|
Jul 28, 2017 11:06AM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
2
|
Resverlogix Corp.
|
Aug 29, 2017 08:37PM
|
|
Re: RVX-208 vs. CETP inhibitors
|
2
|
Resverlogix Corp.
|
Aug 18, 2015 04:34PM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Jan 15, 2016 11:53AM
|
|
Re: Angiochem receives $7.5 million in Series C financing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 03, 2018 12:50PM
|
|
Re: State of Emergency
|
2
|
Resverlogix Corp.
|
Jul 21, 2016 03:55PM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 01:45PM
|
|
Bioasis Announces Bridge Financing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Oct 28, 2019 01:52PM
|
|
Re: Its out on SEDAR...
|
2
|
Resverlogix Corp.
|
Nov 15, 2016 03:41PM
|
|
Re: Will we see 5 point MACE reduction results in BETONMACE
|
2
|
Resverlogix Corp.
|
Jun 15, 2019 01:23PM
|
|
Re: More Than Just DSMB Green Light
|
2
|
Resverlogix Corp.
|
Nov 01, 2017 03:12PM
|
